Logo.png
PSYC Launches Paid Media Partnership Services for Growing Medicinal Psychedelics Industry
July 20, 2021 08:30 ET | Global Trac Solutions, Inc.
PSYC Leverages Use of Its Expanding Psychedelic Spotlight Platform LAKE OSWEGO,OR, July 20, 2021 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”)...
CoreOneLabs_LOGO_COL_LRG_300dpi.png
Core One Labs to Present on its Proprietary Biosynthetic Psilocybin Technology at Investor Town Hall Event on August 4, 2021
July 17, 2021 19:00 ET | Core One Labs Inc.
VANCOUVER, British Columbia, July 17, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Differentiated by Clinical Trials, World-Class Management
July 01, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, July 01, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “GW Pharma Sells for Bilions;...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space
June 30, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
CoreOneLabs_LOGO_COL_LRG_300dpi.png
Core One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings
June 18, 2021 03:00 ET | Core One Labs Inc.
VANCOUVER, British Columbia, June 18, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce it has retained...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Tryp Therapeutics Inc. Chairman and CEO Greg McKee
June 17, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Xphyto logo.jpg
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies
June 15, 2021 11:10 ET | XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...
CoreOneLabs_LOGO_COL_LRG_300dpi.png
REPEAT - Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
June 14, 2021 09:15 ET | Core One Labs Inc.
VANCOUVER, British Columbia, June 14, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce that its...
CoreOneLabs_LOGO_COL_LRG_300dpi.png
Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
June 12, 2021 18:39 ET | Core One Labs Inc.
VANCOUVER, British Columbia, June 12, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce that its...
OH_Logo.png
Optimi Health Announces DTC Eligibility & Up-List to OTCQB
June 03, 2021 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...